Léim ar aghaidh chuig an bpríomhábhar
Gnáthamharc

EU Directives

Dáil Éireann Debate, Tuesday - 7 July 2015

Tuesday, 7 July 2015

Ceisteanna (366)

Fergus O'Dowd

Ceist:

366. Deputy Fergus O'Dowd asked the Minister for Health the way the European cross-border health care directive will operate in County Louth, giving hospital waiting lists in the area; and if he will make a statement on the matter. [27354/15]

Amharc ar fhreagra

Freagraí scríofa

The Health Service Executive operates the EU Directive on Patients’ Rights in Cross Border Healthcare in Ireland through the National Contact Point (NCP) office, which has nationwide responsibility.

In line with practice in other EU Member States, the NCP office, provides information for patients on the Cross-Border Directive on the HSE website: www.hse.ie/eng/services/list/1/schemes/cbd/ - and also by phone. The principal function of the NCP (which is the mechanism specified under the Directive for the dissemination of information on the Directive by Member States) is to facilitate exchange of information for patients concerning their rights and entitlements relating to receiving healthcare in another Member State, in particular the terms and conditions for reimbursement of cost and the procedures for accessing and determining those entitlements.

The NCP also has a responsibility to ensure that all enquirers are informed of the right to healthcare, if any, that they may have through the European legislation on the coordination of social security schemes (EU Regulation 883/04) and which may be more beneficial to them. The NCP is able to inform patients what the cost of their treatments would be in Ireland to allow them make a comparison with the costs they are being quoted for comparable treatment in another Member State.

The healthcare being sought under the CBD can only be healthcare that a person would be entitled to within the public health system in Ireland, which is not contrary to Irish legislation. Referral for care under the CBD can be made by a GP, a hospital consultant and certain other HSE clinicians. It will be a matter for the patient and his/her referring doctor to identify the clinician abroad and satisfy him/herself in relation to the qualifications, quality and safety of the services being availed of in the other jurisdiction.

Prior authorisation may be required from the HSE for certain healthcare. The costs must be borne by the individual and he/she then will seek reimbursement for the cost of the healthcare upon return to Ireland. The HSE will reimburse the patient for care which meets the terms of the CBD in line with the Directive.

Barr
Roinn